Atlas Trials

A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis

Clinical trial NCT06200766 · UNKNOWN

Trial details

NCT number
NCT06200766
Sponsor
Zheng Liu ENT
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Seasonal Allergic Rhinitis
Start date
2023-08-25
Primary completion
2024-04-30
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.